Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Lantus (Insulin Glargine [rDNA Origin]) Injection
Company:  Aventis Pharmaceuticals Inc.
Application No.:  21-081
Approval Date: 4/20/2000


Date created: November 20, 2001

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.